[go: up one dir, main page]

WO2002051424A8 - Drugs against articular failure - Google Patents

Drugs against articular failure

Info

Publication number
WO2002051424A8
WO2002051424A8 PCT/JP2001/011147 JP0111147W WO02051424A8 WO 2002051424 A8 WO2002051424 A8 WO 2002051424A8 JP 0111147 W JP0111147 W JP 0111147W WO 02051424 A8 WO02051424 A8 WO 02051424A8
Authority
WO
WIPO (PCT)
Prior art keywords
failure
drugs against
articular
against articular
aminosugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2001/011147
Other languages
English (en)
French (fr)
Other versions
WO2002051424A1 (en
Inventor
Shigeharu Fukuda
Takeshi Ario
Toshio Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority to EP01994973A priority Critical patent/EP1354590B1/en
Priority to DE60128005T priority patent/DE60128005T2/de
Priority to US10/451,224 priority patent/US20040038929A1/en
Priority to KR1020027010653A priority patent/KR100872681B1/ko
Publication of WO2002051424A1 publication Critical patent/WO2002051424A1/ja
Publication of WO2002051424A8 publication Critical patent/WO2002051424A8/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/10—Chewing gum characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Confectionery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PCT/JP2001/011147 2000-12-22 2001-12-19 Drugs against articular failure Ceased WO2002051424A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP01994973A EP1354590B1 (en) 2000-12-22 2001-12-19 Glucosamine or mannosamine in combination with trehalose against articular failure
DE60128005T DE60128005T2 (de) 2000-12-22 2001-12-19 Glucosamin oder mannosamin in kombination mit trehalose gegen gelenksversagen
US10/451,224 US20040038929A1 (en) 2000-12-22 2001-12-19 Drugs against articular failure
KR1020027010653A KR100872681B1 (ko) 2000-12-22 2001-12-19 관절장해 치료제

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000391390A JP4754066B2 (ja) 2000-12-22 2000-12-22 抗関節障害剤
JP2000-391390 2000-12-22

Publications (2)

Publication Number Publication Date
WO2002051424A1 WO2002051424A1 (en) 2002-07-04
WO2002051424A8 true WO2002051424A8 (en) 2002-08-01

Family

ID=18857537

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/011147 Ceased WO2002051424A1 (en) 2000-12-22 2001-12-19 Drugs against articular failure

Country Status (7)

Country Link
US (2) US20040038929A1 (ja)
EP (1) EP1354590B1 (ja)
JP (1) JP4754066B2 (ja)
KR (1) KR100872681B1 (ja)
DE (1) DE60128005T2 (ja)
TW (1) TWI235660B (ja)
WO (1) WO2002051424A1 (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4143387B2 (ja) * 2002-11-21 2008-09-03 株式会社アセロラフーズ 健康食品
MXPA05008216A (es) * 2003-01-31 2005-10-05 Procter & Gamble Medios para mejorar la apariencia del tejido queratinoso mamifero.
US20050123500A1 (en) * 2003-01-31 2005-06-09 The Procter & Gamble Company Means for improving the appearance of mammalian hair and nails
CN1232256C (zh) * 2003-03-27 2005-12-21 中国人民解放军第三军医大学 N－乙酰氨基葡萄糖在制备治疗自身免疫反应所致的局部损伤或全身症状的药物中的应用
JP2005154281A (ja) * 2003-11-20 2005-06-16 Ominedo Yakuhin Kogyo Kk 関節障害予防及び治療用医薬組成物
JP2006036644A (ja) * 2004-07-22 2006-02-09 Yaizu Suisankagaku Industry Co Ltd グルコサミン顆粒の製造方法、グルコサミン顆粒及びグルコサミン錠剤
WO2006033412A1 (ja) * 2004-09-24 2006-03-30 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo 放射線障害軽減剤
WO2007035057A1 (en) * 2005-09-23 2007-03-29 Gwangju Institute Of Science And Technology Composition for preventing or treating artritis comprising lactic acid bacteria and collangen as active ingredients
CN101646442B (zh) * 2007-02-23 2013-09-04 21世纪国际新技术株式会社 血管痉挛的治疗剂或预防剂
FR2918376B1 (fr) 2007-07-04 2011-10-28 Mathieu Borge Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage
ES2325392B1 (es) 2007-12-28 2010-06-24 Bioiberica, S.A. Composicion para el tratamiento de la artrosis.
JP4973528B2 (ja) * 2008-02-05 2012-07-11 ユーハ味覚糖株式会社 油脂加工食品及びその製造方法
CZ18797U1 (cs) 2008-07-08 2008-08-11 Isoline S.R.O. Prostredek k prevenci kloubních onemocnení
JP2012509289A (ja) * 2008-11-20 2012-04-19 ラボラトリ・デリバティ・オルガニシ・エス・ピー・エイ ヘパラン硫酸の精製方法並びに美容用及び皮膚用調製物中におけるその使用
JP5190083B2 (ja) * 2010-03-26 2013-04-24 花王株式会社 Ｓ１００ａ８発現調節剤
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
RU2740454C2 (ru) 2011-06-03 2021-01-14 Аллерган Эндюстри, Сас Составы кожного наполнителя, включая антиоксиданты
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
US9901648B2 (en) 2012-01-27 2018-02-27 The Regents Of The University Of California Stabilization of biomolecules using sugar polymers
US9012430B2 (en) * 2012-07-24 2015-04-21 Vital Medicine, LLC Compositions and formulations of glucosamine for transdermal and transmucosal administration
MD20150120A2 (ro) 2013-05-07 2016-03-31 Bio Blast Pharma Ltd. Tratamentul bolilor neurodegenerative şi miopatice de agregare proteică prin administrarea parenterală a trehalozei
US9084720B2 (en) 2013-05-07 2015-07-21 BioBlast Pharma Ltd. Compositions and methods for treating oculopharyngeal muscular dystrophy
JP6270362B2 (ja) * 2013-07-17 2018-01-31 日本水産株式会社 関節痛改善剤
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
WO2017102738A1 (en) 2015-12-13 2017-06-22 Verburgh Kris Methods and compositions to slow down aging in cells and organisms
IL291799A (en) 2019-10-01 2022-06-01 Seelos Therapeutics Inc Trehalose formulations and uses thereof
CN119173247A (zh) * 2022-05-06 2024-12-20 不老科学公司 基于软骨素和胶原蛋白肽的用于减缓衰老和延长寿命的方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0571597A4 (en) * 1991-11-15 1994-06-01 Arthro Res & Dev Corp Method for treatment of acute and chronic painful arthropathic conditions in human and other mammals
US5229374A (en) * 1992-01-28 1993-07-20 Burton Albert F Method for treatment of lower gastrointestinal tract disorders
EP0691344B1 (en) 1992-12-28 2003-03-19 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Purification of trehalose
US5364845C1 (en) * 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
JP3559585B2 (ja) 1993-06-03 2004-09-02 株式会社林原生物化学研究所 トレハロース遊離酵素とその製造方法並びに用途
JP3633648B2 (ja) 1993-07-20 2005-03-30 株式会社林原生物化学研究所 マルトース・トレハロース変換酵素とその製造方法並びに用途
US5871993A (en) 1994-02-23 1999-02-16 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses
JP3557272B2 (ja) 1994-02-23 2004-08-25 株式会社林原生物化学研究所 組換え型酵素とその製造方法並びに用途
JP3559609B2 (ja) 1994-03-07 2004-09-02 株式会社林原生物化学研究所 組換え型酵素とその製造方法並びに用途
DE69532485T2 (de) 1994-03-07 2004-11-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Trehalose-freisetzendes Enzym, dafür kodierende DNA, Herstellung und Verwendung
JP3557277B2 (ja) 1994-06-25 2004-08-25 株式会社林原生物化学研究所 耐熱性トレハロース遊離酵素とその製造方法並びに用途
JP3650632B2 (ja) 1994-06-16 2005-05-25 株式会社林原生物化学研究所 マルトースをトレハロースに変換する組換え型酵素
AU695080B2 (en) 1994-06-24 1998-08-06 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Thermostable non-reducing saccharide-forming enzyme, its production and uses
JP3557287B2 (ja) 1994-06-24 2004-08-25 株式会社林原生物化学研究所 耐熱性非還元性糖質生成酵素とその製造方法並びに用途
EP0693558B1 (en) * 1994-07-19 2002-12-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Trehalose and its production and use
JP3557288B2 (ja) 1994-07-21 2004-08-25 株式会社林原生物化学研究所 還元性澱粉糖から末端にトレハロース構造を有する非還元性糖質を生成する組換え型耐熱性酵素
JP3557289B2 (ja) 1994-07-21 2004-08-25 株式会社林原生物化学研究所 非還元性糖質からトレハロースを遊離する組換え型耐熱性酵素
JP3810457B2 (ja) 1994-10-01 2006-08-16 株式会社林原生物化学研究所 マルトースをトレハロースに変換する組換え型耐熱性酵素
JP3084609B2 (ja) * 1995-04-12 2000-09-04 株式会社林原生物化学研究所 トレハロース含有シラップ
US5916565A (en) * 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
ES2241063T3 (es) * 1996-12-13 2005-10-16 Lescarden, Inc. Tratamiento de la osteoartritis mediante la administracion de poli-n-acetil-d-glucosamina.
JP4295840B2 (ja) * 1997-12-09 2009-07-15 株式会社林原生物化学研究所 血行改善剤
JP4442949B2 (ja) * 1998-04-22 2010-03-31 株式会社林原生物化学研究所 抗骨粗鬆症剤
US6440446B1 (en) * 1998-04-22 2002-08-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Agent for anti-osteoporosis
JP3247873B2 (ja) 1998-09-18 2002-01-21 カネボウ株式会社 抗炎症用食品
US6162787A (en) * 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
JP4249853B2 (ja) * 1999-08-09 2009-04-08 焼津水産化学工業株式会社 経口用皮膚潤い改善剤
JP2001072582A (ja) * 1999-09-07 2001-03-21 Sunstar Inc 機能性経口組成物
JP2001302496A (ja) * 2000-04-14 2001-10-31 Takeda Chem Ind Ltd リポソーム製剤
JP2002097143A (ja) * 2000-07-18 2002-04-02 Koyo Chemical Kk 血流改善剤及び血栓予防治療剤または食品

Also Published As

Publication number Publication date
KR20030005193A (ko) 2003-01-17
US20040038929A1 (en) 2004-02-26
KR100872681B1 (ko) 2008-12-10
JP2002193811A (ja) 2002-07-10
EP1354590A4 (en) 2004-07-21
US20050277617A1 (en) 2005-12-15
EP1354590B1 (en) 2007-04-18
WO2002051424A1 (en) 2002-07-04
DE60128005D1 (de) 2007-05-31
EP1354590A1 (en) 2003-10-22
DE60128005T2 (de) 2008-01-03
TWI235660B (en) 2005-07-11
JP4754066B2 (ja) 2011-08-24
US7214667B2 (en) 2007-05-08

Similar Documents

Publication Publication Date Title
WO2002051424A8 (en) Drugs against articular failure
AU7315301A (en) Compounds and compositions for delivering active agents
PL347671A1 (en) Compounds and compositions for delivering active agents
NO20013442L (no) Sammensetninger som oppnar en forbedret levering av aktive stoffer
AU2845599A (en) Pharmaceutical compositions and their use
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
WO2000041681A3 (de) ARZNEIFORMULIERUNGEN ENTHALTEND EIN OPIOID UND EINEN α-AGONISTEN
BR0207930A (pt) Composições farmacêuticas lìquidas com sabor mascarado
IL133397A (en) Pharmaceutical compositions for oral administration comprising an active substance and a cyclodextrin
EP2308479A3 (en) Compounds and compositions for delivering active agents
CA2219065A1 (en) Ophthalmic carrier solution
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
WO2003045306A3 (en) Phenoxy amine compounds and compositions for delivering active agents
AU2001266075A1 (en) Combinations of active ingredients, which exhibit insecticidal and acaricidal properties
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
WO2000066104A3 (en) Ace-2 inhibiting compounds and methods of use thereof
WO2002015959A3 (en) Compounds and compositions for delivering active agents
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
AU2002327097A1 (en) Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient
WO2005117895A8 (en) Compositions comprising meloxicam
EP1066824A3 (en) Stimulative agent and stimulative perfume composition
IL139318A0 (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
AU4317500A (en) Antibiral compositions containing phorbol derivatives as the main active ingredient
WO2004069187A3 (en) Drug formulation and delivery using crystalline methylated cyclodextrins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

AK Designated states

Kind code of ref document: C1

Designated state(s): KR US

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 27/2002 UNDER (51) AFTER "A61K 31/7008" ADD "A61K 31/726"

Free format text: PAT. BUL. 27/2002 UNDER (51) AFTER "A61K 31/7008" ADD "A61K 31/726"

WWE Wipo information: entry into national phase

Ref document number: 1020027010653

Country of ref document: KR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1020027010653

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 10451224

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2001994973

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001994973

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2001994973

Country of ref document: EP